menu search

Biophytis shares surge 41% following covid partnership with france's skyepharma

Shares of Biophytis (NASDAQ:BPTS, EPA:AlbpS), a clinical-stage biotechnology firm, soared 41% in premar...

September 25, 2023, 9:12 am

Biophytis to participate at the h.c. wainwright 25th global investment conference in new york

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / September 4, 2023 / Biophytis SA (Nasdaq CM:BPTS, Euronext Growth Paris:A...

September 4, 2023, 5:30 pm

Liberty gold reports additional high-grade drill results, including a new discovery at its black pine oxide gold project, idaho

Au over 65.5 m including 2.47 g/t Au over 10.7 m in lbp932 from the Discovery Zone 1.41 g/t Au over 30....

July 24, 2023, 10:44 am

Aegon (aeg) extends jv partnership in lbp am through 2035

The JV partnership extension will likely enable Aegon (AEG) to generate further growth from the multi-specialist investment manager space....

July 5, 2023, 12:17 pm

Longboard pharmaceuticals, inc. (lbph) is on the move, here's why the trend could be sustainable

Longboard Pharmaceuticals, Inc. (lbpH) could be a solid choice for shorter-term investors looking to ca...

May 1, 2023, 9:55 am

Aclarion skyrockets on positive trial data for lower back pain intelligence platform

Aclarion shares skyrocketed after the company published data from a two-year trial that demonstrated improved surgical outcomes for discogenic lower b...

April 24, 2023, 11:46 am

Recent price trend in longboard pharmaceuticals, inc. (lbph) is your friend, here's why

Longboard Pharmaceuticals, Inc. (lbpH) made it through our "Recent Price Strength" screen and could be ...

April 14, 2023, 9:52 am

Does longboard pharmaceuticals, inc. (lbph) have the potential to rally 208.22% as wall street analysts expect?

The mean of analysts' price targets for Longboard Pharmaceuticals, Inc. (lbpH) points to a 208.2% upsid...

April 7, 2023, 11:29 am

Biophytis to present positive results of phase 2-3 cova study at ers 2023 21st lung science conference

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / March 9, 2023 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:A...

March 9, 2023, 2:20 am

Longboard pharmaceuticals, inc. (lbph) q4 2022 results - earnings call transcript

Longboard Pharmaceuticals, Inc. (NASDAQ:lbpH ) Q4 2022 Results Earnings Conference Call March 2, 2023 4...

March 2, 2023, 11:12 pm

Longboard pharmaceuticals to report full year 2022 financial results and key corporate initiatives on march 2, 2023

SAN DIEGO--(BUSINESS WIRE)---- $lbpH #Epilepsy--Longboard Pharmaceuticals, Inc. (Nasdaq: ...

February 23, 2023, 4:31 pm

Chf/lbp – swiss franc lebanese pound

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your inves...

February 10, 2023, 4:14 pm

4d pharma says phase ii ibs results published in scientific journal

4D pharma PLC said results from a phase II evaluation of its key irritable bowel treatment lbp Blautix ...

November 16, 2022, 2:47 am

Relievant medsystems announces updated policy statement and guideline for basivertebral nerve ablation from the international society for the advancement of spine surgery

MINNEAPOLIS, Nov. 08, 2022 (GLOBE NEWSWIRE) — Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic...

November 8, 2022, 9:30 pm

Longboard pharmaceuticals to present at the 2022 wedbush pacgrow healthcare virtual conference

SAN DIEGO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: lbpH), a clinical...

August 3, 2022, 8:30 am

4d pharma outlines phase ii plans for promising cancer drug candidate

4D pharma PLC (AIM:DDDD, NASDAQ:lbpS) will deliver what's called a ‘trial in progress' poster at a wo...

May 27, 2022, 2:50 am

4d pharma conference poster underlines safety and potential efficacy of asthma drug candidate

4D pharma PLC (AIM:DDDD, NASDAQ:lbpS) said it will present an update from the phase I/II trial of its p...

May 17, 2022, 2:29 am

4d pharma has a busy year ahead after a successful 12 months of clinical research

4D pharma PLC (AIM:DDDD, NASDAQ:lbpS) has some significant milestones upcoming this year after a succes...

April 1, 2022, 3:29 am

4d pharma plc soars after meeting endpoint early

4D pharma PLC (AIM:DDDD, NASDAQ:lbpS) jumped 27% in London trading after the company hit its primary ef...

March 23, 2022, 12:02 pm

4d pharma shares soar on mrx0518/keytruda combo trial data in renal cell carcinoma

4D pharma plc (NASDAQ: lbpS) has announced interim results from Phase 1/2 study evaluating the combi...

March 23, 2022, 9:43 am


Search within

Pages Search Results: